title: Enhanced phagocytosis of rat alveolar macrophages by intravenous infusion of an arginine-enriched solution.
abstract: Phagocytosis of rat alveolar macrophages (AM) was enhanced by the infusion of arginine-rich solution for 7 days. The enhancement of phagocytosis by arginine-rich solution was due to not the difference in the distribution of AM subpopulations (I to IV) but the difference in phagocytic activity of AM in fraction IV. In the process of phagocytosis, there were no significant differences in the stages of migration, attachment, and digestion between control and arginine-rich solutions, although AM from fraction IV of rats infused with arginine-rich solution showed significantly higher ingestion of opsonized sheep red blood cells (SRBC) compared to that of control group. Furthermore, the production of macrophage-activating factor (MAF) from rat splenocytes was higher in arginine-rich group than that of control group. AM from fraction IV of rats fed a stock diet had a higher arginase activity and showed a significant increase of phagocytosis following in vitro incubation with L-arginine (25 and 50 mM) for 24 h. From these results, the enhanced phagocytosis of AM by arginine-rich solution may be due to the increased phagocytosis of AM from fraction IV, in which the higher sensitivity of AM from fraction IV to arginine and the higher production of MAF from splenocytes following the infusion of arginine-rich solution participate.
authors.affiliation: Department of Nutrition, School of Medicine, University of Tokushima, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Nii
authors.forename: S
authors.initials: S
authors.lastname: Moriguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Kishino
mesh_terms: D000596:Amino Acids / Q000097:blood; D000818:Animals; D001119:Arginase / Q000378:metabolism; D001120:Arginine / Q000008:administration & dosage* / Q000494:pharmacology; D001835:Body Weight; D002401:Cathepsin B / Q000378:metabolism; D002452:Cell Count; D002465:Cell Movement; D007700:Kinetics; D016215:Macrophage-Activating Factors / Q000494:pharmacology; D016676:Macrophages, Alveolar / Q000166:cytology / Q000502:physiology*; D008297:Male; D009929:Organ Size; D010587:Phagocytosis / Q000187:drug effects*; D051381:Rats; D011916:Rats, Inbred F344; D012996:Solutions; D013154:Spleen / Q000166:cytology; D013950:Thymus Gland / Q000166:cytology
chemical_list: D000596:Amino Acids; D016215:Macrophage-Activating Factors; D012996:Solutions; D001120:Arginine; D002401:Cathepsin B; D001119:Arginase